Synergism between ATM and PARP1 Inhibition Involves DNA Damage and Abrogating the G2 DNA Damage Checkpoint

Joyce P Y Mak1, Hoi Tang Ma1, Randy Y C Poon2

  • 1Division of Life Science, Center for Cancer Research, and State Key Laboratory of Molecular Neuroscience, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.

Insights

Inhibiting ATM and PARP1 together causes significant DNA damage, activating cell cycle checkpoints. ATM

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Poly (ADP-ribose) polymerase (PARP) inhibitors are effective for BRCA1/BRCA2-deficient cancers.
  • ATM protein is a potential target for synthetic lethality with PARP inhibitors.
  • The cellular response to combined ATM and PARP1 inhibition requires precise definition.

Purpose of the Study:

  • To elucidate the precise cellular response to combined inhibition of ATM and PARP1.
  • To investigate the role of ATM in DNA repair for synergism with PARP inhibitors.
  • To explore the mechanisms underlying the synergistic effects of ATM and PARP1 inhibition.

Main Methods:

  • Utilized ATM-deficient cell lines and ATM inhibitors (KU-60019, AZD0156).
  • Employed PARP1 deletion and PARP inhibitors (olaparib, veliparib).
  • Analyzed DNA damage, PARylation levels, and G2 DNA damage checkpoint activation (ATR, CHK1/2, WEE1).

Main Results:

  • Loss of ATM function leads to spontaneous DNA damage and increased PARylation.
  • Combined ATM and PARP1 inhibition activates the G2 DNA damage checkpoint cascade.
  • ATM's role in DNA repair is critical for synergism with PARP inhibitors.
  • PARP1 inhibition is more critical than other PARP isoforms for this synergism.
  • PARP1 deletion enhances sensitivity to ATM inhibitors, suggesting mechanisms beyond PARP1 trapping.

Conclusions:

  • ATM inhibition combined with PARP1 inhibition induces significant DNA damage and activates checkpoints.
  • ATM's DNA repair function is essential for the synergistic effect with PARP inhibitors.
  • The findings provide a mechanistic basis for targeting ATM and PARP1 concurrently in cancer therapy.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.9K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
6.2K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K